Tricyclic antidepressant
 | This article is a stub. The talk page may contain suggestions. |
A tricyclic antidepressant is a type of antidepressant named for its three-ringed chemical structure.[1] Tricyclic antidepressants can be an effective treatment for depression but are less commonly used now that alternatives with fewer side effects exist.[1] However, they remain a good option if those treatments are not effective in a given case.[1]
Approved tricyclic antidepressants[edit | edit source]
As of June 2016, the FDA has approved the following tricyclic antidepressants to treat depression:[1]
- Amitriptyline
- Amoxapine
- Desipramine (Norpramin)
- Doxepin
- Imipramine (Tofranil)
- Nortriptyline (Pamelor)
- Protriptyline (Vivactil)
- Trimipramine (Surmontil)
Use in ME[edit | edit source]
Tricyclic antidepressants such as amitriptyline or clomipramine are commonly used in ME/CFS to treat chronic pain and to aid regular sleep.[citation needed]
See also[edit | edit source]
References[edit | edit source]
- ↑ 1.01.11.21.3 "Tricyclic antidepressants (TCAs)". Mayo Clinic. Retrieved January 9, 2019.
adverse reaction Any unintended or unwanted response to a treatment, whether in a clinical trial or licensed treatment. May be minor or serious.
The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.
